Posts

FDA Grants Interchangeable Designation to Yuflyma (adal...

May 12, 2025 0

INCHEON, South Korea, April 14, 2025 /-- Celltrion, Inc. today announced that th...

FDA Warns Patients and Health Care Professionals Not to Use Compounded Drugs from Fullerton Wellness

FDA Warns Patients and Health Care Professionals Not to...

May 12, 2025 0

Audience: Patients, Health Care Professionals November 1, 2024 -- FDA is warning...

Do Not Purchase or Use Skin-Cap Aerosol Spray Products Because They May Be Harmful to Your Health

Do Not Purchase or Use Skin-Cap Aerosol Spray Products ...

May 12, 2025 0

Audience: Consumers October 30, 2024 -- FDA is warning consumers to not purchase...

Public Safety Notification on Amniotic Fluid Eyedrops

Public Safety Notification on Amniotic Fluid Eyedrops

May 12, 2025 0

Audience: Patients, Health Care Practitioners October 17, 2024 Update: In August...

Staska Pharmaceuticals, Inc. Issues Recall of Ascorbic Acid Solution for Injection (Preservative Free, Non-Corn) 500mg/mL Due to the Presence of Glass Particles

Staska Pharmaceuticals, Inc. Issues Recall of Ascorbic ...

May 12, 2025 0

Audience: Healthcare Provider, Pharmacy October 16, 2024 -- Bennet, NE -- STASKA...

FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize

FDA Clarifies Policies for Compounders as National GLP-...

May 12, 2025 0

Audience: Industry October 2, 2024 -- The U.S. Food and Drug Administration has ...

FDA is Alerting Patients and Health Care Professionals About the Voluntary Withdrawal of Oxbryta from the Market Due to Safety Concerns

FDA is Alerting Patients and Health Care Professionals ...

May 12, 2025 0

Audience: Health Care Professionals, Patients September 26, 2024 -- FDA is alert...

Gilead Issues Voluntary Nationwide Recall of One Lot of Veklury (Remdesivir) for Injection 100 mg/vial Due to the Presence of a Glass Particle

Gilead Issues Voluntary Nationwide Recall of One Lot of...

May 12, 2025 0

Audience: Healthcare Provider, Pharmacy Foster City, Calif., September 20, 2024 ...

FDA Approves Imaavy (nipocalimab-aahu) for the Treatment of Generalized Myasthenia Gravis (gMG)

FDA Approves Imaavy (nipocalimab-aahu) for the Treatmen...

May 12, 2025 0

SPRING HOUSE, Pa., (April 30, 2025) – Johnson & Johnson (NYSE: JNJ) today announ...

FDA Approves Atzumi (dihydroergotamine) Nasal Powder for the Acute Treatment of Migraine

FDA Approves Atzumi (dihydroergotamine) Nasal Powder fo...

May 12, 2025 0

DURHAM, N.C., April 30, 2025 /PRNewswire/ -- Satsuma Pharmaceuticals, Inc., a la...

Shoppers-Plaza Issues Voluntary Nationwide Recall of Fouzee Sugarlin Herbal Formula Due To Presence Of Undeclared Metformin And Glyburide

Shoppers-Plaza Issues Voluntary Nationwide Recall of Fo...

May 12, 2025 0

Audience: Consumer December 16, 2024 – Los Angeles, California - Shoppers-Plaza ...

FDA Adds Boxed Warning to Veozah (fezolinetant) to Highlight the Known Risk of Rare But Serious Liver Injury

FDA Adds Boxed Warning to Veozah (fezolinetant) to High...

May 12, 2025 0

Audience: Patient, Health Professional, OBGYN, Endocrinology Update: December 16...

Drug Safety Communication: Ocaliva (obeticholic acid) - Serious Liver Injury Being Observed in Patients without Cirrhosis

Drug Safety Communication: Ocaliva (obeticholic acid) -...

May 12, 2025 0

Audience: Gastroenterology, Hepatology, Patient, Health Care Professional, Pharm...

Buy-herbal.com Issues Voluntary Nationwide Recall of Nhan Sam Tuyet Lien Truy Phong Hoan Capsules Due to Undeclared Furosemide, Dexamethasone and Chlorpheniramine

Buy-herbal.com Issues Voluntary Nationwide Recall of Nh...

May 12, 2025 0

Audience: Consumer Flushing, New York, Buy-herbal.com is voluntarily recalling a...

FDA Investigating Serious Risk of Hematologic Malignancy Following Skysona (elivaldogene autotemcel)

FDA Investigating Serious Risk of Hematologic Malignanc...

May 12, 2025 0

Audience: Health Professional November 27, 2024 -- Since approval, the Food and ...

Mxbbb Issues Voluntary Nationwide Recall of Umary Acid Hyaluronic Due to the Presence of Diclofenac and Omeprazole

Mxbbb Issues Voluntary Nationwide Recall of Umary Acid ...

May 12, 2025 0

Audience: Healthcare Provider, Pharmacy, Consumer November 20, 2024 -- MXBBB is ...

Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling

Endo Expands Voluntary Recall of Clonazepam Orally Disi...

May 12, 2025 0

Audience: Healthcare Provider, Pharmacy, Consumer November 19, 2024 -- Endo, Inc...

VitalityVita Issues Voluntary Nationwide Recall of VitalityXtra and PeakMax Capsules Due to the Presence of Undeclared Sildenafil and Diclofenac

VitalityVita Issues Voluntary Nationwide Recall of Vita...

May 12, 2025 0

Audience: Consumers November 4, 2024 – Sacramento, CA, VitalityVita.com is volun...

Boulla LLC Issues Voluntary Nationwide Recall of ZoomMax and ZapMax Capsules Due to the Presence of Undeclared Sildenafil and Diclofenac

Boulla LLC Issues Voluntary Nationwide Recall of ZoomMa...

May 12, 2025 0

Audience: Consumers November 4, 2024 – Sacramento, CA, Boulla LLC is voluntarily...

Endo USA, Inc. Issues Voluntary, Nationwide Recall of Adrenalin® Chloride Solution (EPINEPHrine Nasal Solution, USP) Due to the Potential for Administration Errors

Endo USA, Inc. Issues Voluntary, Nationwide Recall of A...

May 12, 2025 0

Audience: Healthcare Professional, Pharmacy, Consumer MALVERN, PA, December 20, ...

Johnson & Johnson’s TAR-200 Monotherapy Demonstrates Highest Complete Response Rate with Sustained Clinical Benefits in Patients with Certain Types of Bladder Cancer

Johnson & Johnson’s TAR-200 Monotherapy Demonstrates Hi...

May 12, 2025 0

LAS VEGAS, April 26, 2025 – Johnson & Johnson (NYSE: JNJ) today announced new da...

Health Fixer Issues Voluntary Nationwide Recall of Male Ultra, Malextra, Electro Buzz, Ultra Armor and Male Ultra Pro

Health Fixer Issues Voluntary Nationwide Recall of Male...

May 12, 2025 0

Audience: Consumer April 25, 2025 – Tempe, AZ, HEALTH FIXER is voluntarily recal...

Boehringer’s New Zongertinib Data Demonstrates Durable and Clinically Meaningful Results in Patients with HER2 (ERBB2)-Mutant Advanced NSCLC

Boehringer’s New Zongertinib Data Demonstrates Durable ...

May 12, 2025 0

Ingelheim, Germany / Ridgefield, Conn., U.S., April 28, 2025 - Boehringer Ingelh...

Johnson & Johnson’s TAR-200 Monotherapy Achieves High Disease-Free Survival of More Than 80 Percent in BCG-Unresponsive, High-Risk Papillary NMIBC

Johnson & Johnson’s TAR-200 Monotherapy Achieves High D...

May 12, 2025 0

LAS VEGAS, April 26, 2025 – Johnson & Johnson (NYSE: JNJ) today announced first ...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.